Celldex Therapeutics reported $668K in Sales Revenues for its third fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Abbvie ABBV:US $ 13858M 956M
Agenus AGEN:US $ 14.83M 12.11M
Amgen AMGN:US $ 6634M 211M
Applied Genetic Technologies AGTC:US $ 0M 0M
Aptinyx Inc APTX:US $ 257K 233K
Arena Pharmaceuticals ARNA:US $ 0.04M 0.02M
Biocept BIOC:US $ 6.59M 5.67M
Bristol Myers Squibb BMY:US $ 11068M 528M
Celldex Therapeutics CLDX:US $ 0.67M 0.43M
Glaxosmithkline GSK:US $ 8739M 93M
Immunogen IMGN:US $ 85.8M 67.61M
Newlink Genetics NLNK:US $ 0.07M 0.04M
Pfizer PFE:US $ 11684M 447M
Rigel Pharmaceuticals RIGL:US $ 18.39M 2.37M
Seattle Genetics SGEN:US $ 601.29M 460.44M